INTERVIEW: Making PhRMA the great convener: Chin's new quest
This article was originally published in SRA
Executive Summary
Donna Young went to meet William Chin, the new head of science and regulatory affairs at US pharma industry association PhRMA, to discuss the need for partnership and collaboration in drug development to meet the progression of disease.